Kum Kum Khanna Selected Research

alpha-Crystallin B Chain

1/2023

Alpha-B-Crystallin overexpression is sufficient to promote tumorigenesis and metastasis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kum Kum Khanna Research Topics

Disease

53	Neoplasms (Cancer) 01/2024 - 02/2002
30	Breast Neoplasms (Breast Cancer) 04/2023 - 07/2004
18	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017 - 02/2002
12	Triple Negative Breast Neoplasms 07/2021 - 06/2013
9	Genomic Instability 10/2020 - 05/2008
8	Carcinogenesis 01/2023 - 01/2012
7	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2010
6	Chromosomal Instability (Chromosome Stability) 01/2024 - 08/2009
5	Chromosome Aberrations (Chromosome Abnormalities) 11/2017 - 12/2006
4	Melanoma (Melanoma, Malignant) 01/2017 - 12/2014
2	Carcinoma (Carcinomatosis) 01/2023 - 12/2022
2	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 12/2022 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 10/2002
2	Brain Neoplasms (Brain Tumor) 01/2020 - 02/2015
2	Inflammation (Inflammations) 01/2016 - 02/2014
2	Familial Breast Cancer 05/2014 - 08/2006
2	Alzheimer Disease (Alzheimer's Disease) 07/2011 - 04/2010
2	Muscular Diseases (Myopathy) 12/2010 - 04/2010
2	Hypersensitivity (Allergy) 04/2010 - 08/2009
1	Aneuploidy (Aneuploid) 01/2024
1	Starvation 01/2023
1	Xeroderma Pigmentosum (Kaposi's Disease) 10/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2021
1	Hematologic Diseases (Blood Diseases) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Multiple Myeloma 01/2020
1	Circulating Neoplastic Cells 01/2020
1	Lymphoma (Lymphomas) 01/2019

Drug/Important Bio-Agent (IBA)

20	DNA (Deoxyribonucleic Acid)IBA 07/2018 - 07/2005
19	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2004
15	Phosphotransferases (Kinase)IBA 01/2019 - 11/2004
6	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2017 - 07/2009
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022 - 10/2009
5	Transcription Factors (Transcription Factor)IBA 07/2021 - 05/2006
4	ChromatinIBA 12/2022 - 07/2005
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2014
4	Selenoproteins (Selenoprotein)IBA 02/2014 - 07/2007
3	Phenobarbital (Luminal)FDA Link 04/2023 - 02/2015
3	Thioredoxin-Disulfide ReductaseIBA 01/2023 - 01/2020
3	CX 5461IBA 05/2021 - 08/2016
3	Estrogen ReceptorsIBA 01/2019 - 01/2010
3	Protein Kinases (Protein Kinase)IBA 07/2011 - 02/2002
3	Caffeine (No Doz)FDA LinkGeneric 07/2011 - 12/2005
2	ProteomeIBA 01/2024 - 01/2023
2	Hormones (Hormone)IBA 04/2023 - 08/2017
2	AntioxidantsIBA 01/2023 - 12/2010
2	Auranofin (Ridaura)FDA Link 01/2023 - 01/2020
2	ThioredoxinsIBA 01/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 05/2021 - 11/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 01/2017
2	Cadherins (E-Cadherin)IBA 01/2019 - 01/2018
2	AntigensIBA 01/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 11/2018 - 01/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017 - 08/2006
2	Small Interfering RNA (siRNA)IBA 03/2016 - 07/2004
2	LigandsIBA 11/2015 - 02/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2015 - 01/2010
2	CamptothecinIBA 06/2014 - 03/2013
2	SeleniumIBA 02/2014 - 07/2007
2	Ataxia Telangiectasia Mutated ProteinsIBA 09/2013 - 11/2004
2	Monoclonal AntibodiesIBA 06/2013 - 02/2013
2	Selenium CompoundsIBA 04/2010 - 07/2007
2	Carrier Proteins (Binding Protein)IBA 10/2009 - 12/2008
2	DNA-Binding Proteins (DNA Binding Protein)IBA 08/2009 - 05/2008
1	CopperIBA 04/2023
1	alpha-Crystallin B ChainIBA 01/2023
1	Crystallins (Crystallin)IBA 01/2023
1	CarcinogensIBA 01/2023
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2023
1	CB-839IBA 01/2023
1	GlutaminaseIBA 01/2023
1	Glutamine (L-Glutamine)FDA Link 01/2023
1	Thioredoxin Reductase 1IBA 01/2023
1	CBLC137IBA 12/2022
1	olaparibIBA 12/2022
1	2-tert-butylhydroquinone (tert-butylhydroquinone)IBA 07/2021
1	RNA Polymerase IIIIBA 07/2021
1	Oxidants (Oxidizing Agents)IBA 07/2021
1	Bexarotene (LGD1069)FDA Link 07/2021
1	GlycosphingolipidsIBA 07/2021
1	RNA Polymerase I (Polymerase I, RNA)IBA 05/2021
1	eprenetapoptIBA 05/2021
1	salinomycinIBA 01/2020
1	marizomibIBA 01/2020
1	phosphine (phosphane)IBA 01/2020
1	IonophoresIBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	GoldIBA 01/2020
1	Proteasome InhibitorsIBA 01/2020
1	UbiquitinIBA 07/2019
1	Ligases (Synthetase)IBA 07/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2019
1	BenzimidazolesIBA 01/2019
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 01/2019

Therapy/Procedure

25	Therapeutics 01/2024 - 08/2006
8	Drug Therapy (Chemotherapy) 01/2020 - 08/2006
2	Radiotherapy 01/2020 - 08/2006
2	Immunotherapy 01/2018 - 12/2014
2	Radioimmunotherapy 06/2014 - 06/2013
1	Precision Medicine 01/2020